Fifth Circuit Reinstates Mifepristone In-Person Dispensing Requirement NationwideMay 22, 2026Legal NewsThe Fifth Circuit reinstated mifepristone's in-person dispensing requirement nationwide on May 1, accepting Louisiana's Medicaid-cost standing theory before the Supreme Court intervened May 4.
Supreme Court Freezes 5th Circuit Order Blocking Mail-Order MifepristoneMay 22, 2026Legal NewsThe Supreme Court indefinitely froze a 5th Circuit ruling that would have ended mail-order mifepristone access, as Alito and Thomas dissented and the Comstock Act emerged as a new front.
Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.
22-State Coalition Urges Supreme Court to Stay Fifth Circuit Mifepristone RulingMay 6, 2026Law and PolicyA 22-state coalition and Connecticut filed separate amicus briefs asking the Supreme Court to stay the Fifth Circuit's mifepristone in-person dispensing ruling before a May 11 deadline.
5th Circuit Orders FDA to Reinstate Mifepristone In-Person RequirementMay 6, 2026Law and PolicyThe Fifth Circuit ordered the FDA to reinstate in-person mifepristone dispensing on May 1, 2026; the Supreme Court stayed the ruling three days later.
Alito Issues One-Week Stay Blocking Fifth Circuit Mifepristone RulingMay 6, 2026Law and PolicyJustice Alito issued a one-week administrative stay on May 4, 2026, blocking a Fifth Circuit ruling that would have banned mail-order mifepristone access nationwide.